Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

AHA Marks 100 Years: ‘We Truly Stand on the Shoulders of Giants’

L.A. McKeown

January 08, 2024

News Daily News

Cardiologist Robert Califf Nominated to Head FDA—Again

Shelley Wood

November 12, 2021

News Daily News

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

Todd Neale

December 16, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

Female Mentors Likely Play Key Role in Boosting Numbers of Female ‘Corresponding’ Authors

Shelley Wood

February 21, 2019

News Daily News

Open Questions: Cardiology Editors and Academics Mull Data-Sharing Pitfalls and Potential

Shelley Wood

July 04, 2018

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

Twitter Review Reveals Clues as to Who, When, and What Users Are Tweeting About Cardiovascular Disease Online

Yael L. Maxwell

September 28, 2016

News Daily News

Galen Strohm Wagner, Who Helped Establish the Duke Databank for Cardiovascular Disease, Dies Age 76

Michael H. Wilson

July 14, 2016

News Daily News

Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects

Shelley Wood

January 18, 2016

News Daily News

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Shelley Wood

January 18, 2016

News Daily News

Antiguo Miembro de la FDA Dice que los Datos que Faltan sobre Ensayos Antitrombóticos arrojan una Sombra sobre los Efectos del Fármaco

Shelley Wood

January 18, 2016

News Daily News

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Caitlin E. Cox

April 26, 2012

News Daily News

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Caitlin E. Cox

April 26, 2012

News Daily News

Mitral Repair Can Augment Heart Function in CABG Patients

Caitlin E. Cox

March 04, 2012

News Daily News

La Reparación Mitral Puede Aumentar la Función Cardíaca en Pacientes sometidos a CABG

Caitlin E. Cox

March 04, 2012

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

Advertisement

BMJ Investigation Revives Questions About PLATO, Ticagrelor

AHA Marks 100 Years: ‘We Truly Stand on the Shoulders of Giants’

Cardiologist Robert Califf Nominated to Head FDA—Again

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Female Mentors Likely Play Key Role in Boosting Numbers of Female ‘Corresponding’ Authors

Open Questions: Cardiology Editors and Academics Mull Data-Sharing Pitfalls and Potential

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Twitter Review Reveals Clues as to Who, When, and What Users Are Tweeting About Cardiovascular Disease Online

Galen Strohm Wagner, Who Helped Establish the Duke Databank for Cardiovascular Disease, Dies Age 76

Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects

FDA 的前职员表示，各抗血栓试验的缺失数据使得药物作用蒙上疑云

Antiguo Miembro de la FDA Dice que los Datos que Faltan sobre Ensayos Antitrombóticos arrojan una Sombra sobre los Efectos del Fármaco

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Mitral Repair Can Augment Heart Function in CABG Patients

La Reparación Mitral Puede Aumentar la Función Cardíaca en Pacientes sometidos a CABG

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content